Lv1
50 积分 2024-05-09 加入
Real‐World Patient Experience With Erenumab for the Preventive Treatment of Migraine
8天前
已完结
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults
9天前
已完结
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment
9天前
已完结
Rimegepant: Acute Treatment for Migraine Headaches
10天前
已完结
CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
12天前
已完结
Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
15天前
已完结
皖公网安备34019202002308
